ClinicalTrials.govpublic full text
Phase I/II Study of ASP9521 in Castrate-Resistant Prostate Cancer (CRPC) Patients
castrate resistant prostate cancer, asp9521, phase 1/2, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 807309
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.